145 results on '"Park, Huiyul"'
Search Results
2. A survey on the awareness, current management, and barriers for non-alcoholic fatty liver disease among the general Korean population
3. Diagnostic Performance of Noninvasive Tests for Advanced Hepatic Fibrosis in Young Age Population
4. Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients
5. Nomenclature Dilemma of Metabolic Associated Fatty Liver Disease (MAFLD): Considerable Proportions of MAFLD Are Metabolic Healthy
6. SAT-465 Increasing awareness among primary care physicians about MASLD reduced unnecessary referral rates and an increased cardiovascular evaluation
7. SAT-296 Prevalence and characteristics of MASLD with greater alcohol consumption (MetALD) in the general population
8. SAT-284 Diagnostic performance of non-invasive tests in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) with increased alcohol intake (MetALD) in a primary care setting
9. FRI-223 Cost-effectiveness of one-time screening for advanced hepatic fibrosis using FIB-4 based two-step algorithm in the general population
10. WED-323 Diagnostic performances of FIB-4 and NFS in metabolic dysfunction-associated steatotic liver disease in primary care clinic of Asia
11. Diagnostic performances of Fibrosis‐4 index and nonalcoholic fatty liver disease fibrosis score in metabolic dysfunction‐associated steatotic liver disease in Asian primary care clinics.
12. Cost‐effectiveness study of FIB‐4 followed by transient elastography screening strategy for advanced hepatic fibrosis in a NAFLD at‐risk population
13. Cost-Effectiveness of One-Time Screening for Advanced Hepatic Fibrosis Using FIB-4 Based Two-Step Algorithm in the General Population
14. Diagnostic performance of the fibrosis-4 index and the NAFLD fibrosis score for screening at-risk individuals in a health check-up setting
15. Genetic and Metabolic Characteristics of Lean Nonalcoholic Fatty Liver Disease in a Korean Health Examinee Cohort
16. Letter to the Editor: Is lifestyle modification effective for individuals with high fibrosis-4 index without an additional second-tier test?
17. Cost effectiveness analysis of screening for advanced hepatic fibrosis in patients with various ‘at-risk population’ in guidelines
18. Deletion of mixed lineage kinase domain like pseudokinase aggravate chronic alcohol induced liver injury via increasing apoptosis
19. Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver disease
20. Genetic and metabolic characteristics of lean non-alcoholic fatty liver disease in Asian
21. Diagnostic performance of fibrosis-4 index and NAFLD fibrosis score in at-risk group from low prevalence population
22. Cost-effectiveness of screening for advanced hepatic fibrosis by non-invasive test in general population
23. Diagnostic performance of NAFLD fibrosis score in lean NAFLD
24. Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
25. Diagnostic Performance of Noninvasive Tests for Advanced Hepatic Fibrosis in Young Age Population
26. Lemon balm extract ALS-L1023, an angiogenesis inhibitor, inhibits liver fibrosis in a non-alcoholic fatty liver disease model
27. Comparison of diagnostic performance between FIB-4 and NFS in metabolic-associated fatty liver disease era
28. Can combination of M2BPGi and APRI help endocrinologists refer patients with advanced hepatic fibrosis to hepatologists?
29. Peripheral blood mononuclear cells mitochondrial copy number and adenosine triphosphate inhibition test in non-alcoholic fatty liver disease
30. Reply
31. A re-appraisal of the diagnostic performance of ultrasonography for fatty liver disease
32. Presence of two or more metabolic risks regardless of fatty liver is a risk factor for significant hepatic fibrosis
33. Direct-acting antivirals and the risk of hepatitis B reactivation in hepatitis B and C coinfected patients: a systematic review and meta-analysis
34. Ticagrelor, but not clopidogrel, attenuated hepatic steatosis in a model of non-alcoholic fatty liver disease
35. The protective role of dairy protein on sarcopenic obesity in middle-aged and older women: a community-based, 12-year, prospective cohort study
36. Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction‐associated fatty liver disease in Korea
37. Nomenclature Dilemma of Metabolic Associated Fatty Liver Disease (MAFLD): Considerable Proportions of MAFLD Are Metabolic Healthy
38. Selecting the Target Population for Screening of Hepatic Fibrosis in Primary Care Centers in Korea
39. Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans
40. Comparison of diagnostic performance between FIB‐4 and NFS in metabolic‐associated fatty liver disease era
41. Fibrosis Burden of Missed and Added Populations According to the New Definition of Metabolic Dysfunction-Associated Fatty Liver
42. Do we need a new cut-off for FIB-4 in the metabolic dysfunction-associated fatty liver disease era?
43. Diabetes is the strongest risk factor of hepatic fibrosis in lean patients with non-alcoholic fatty liver disease
44. New sequential algorithm using Mac-2 binding protein glycosylation isomer to detect advanced carotid artery atherosclerosis
45. WED-531 - Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver disease
46. WED-435 - Deletion of mixed lineage kinase domain like pseudokinase aggravate chronic alcohol induced liver injury via increasing apoptosis
47. SAT-462 - Diagnostic performance of fibrosis-4 index and NAFLD fibrosis score in at-risk group from low prevalence population
48. SAT-475 - Diagnostic performance of NAFLD fibrosis score in lean NAFLD
49. SAT-470 - Cost-effectiveness of screening for advanced hepatic fibrosis by non-invasive test in general population
50. SAT-418 - Cost effectiveness analysis of screening for advanced hepatic fibrosis in patients with various ‘at-risk population’ in guidelines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.